Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism


Author index

Page Path
Borami Kang  (Kang B) 1 Article
Cholestyramine Use for Rapid Reversion to Euthyroid States in Patients with Thyrotoxicosis
Jeonghoon Ha, Kwanhoon Jo, Borami Kang, Min-Hee Kim, Dong-Jun Lim
Endocrinol Metab. 2016;31(3):476-479.   Published online July 26, 2016
  • 3,828 View
  • 51 Download
  • 6 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   

Cholestyramine (CS) is an ion exchange resin, which binds to iodothyronines and would lower serum thyroid hormone level. The use of CS added to conventional antithyroid drugs to control thyrotoxicosis has been applied since 1980's, and several studies indicate that using CS in combination with methimazole (MZ) produces a more rapid decline in serum thyroid hormones than with only MZ treatment. Our recent retrospective review of five patients taking high dose MZ and CS, compared to age-, gender-, initial free thyroxine (T4) level-, and MZ dose-matched 12 patients with MZ use only, showed more rapid decline of both free T4 and triiodothyronine levels without more adverse events. CS could be safely applicable short-term adjunctive therapy when first-line antithyroid medications are not enough to adequately control severe thyrotoxicosis or side effects of antithyroid drug would be of great concern.


Citations to this article as recorded by  
  • Therapeutic plasma exchange for Graves’ disease in pregnancy
    Matthew Lumchee, Mimi Yue, Josephine Laurie, Adam Morton
    Obstetric Medicine.2023; 16(2): 126.     CrossRef
  • Ventricular arrhythmias, antiarrhythmic therapy and thyroidal illness in advanced heart failure: a case report and review of the literature
    Fatima Alsalama, Salma Alzaabi, Cynthia Salloum, Marilyne Abi Younes, Feras Bader, Hussam Ghalib, Bassam Atallah
    Drugs & Therapy Perspectives.2023; 39(4): 147.     CrossRef
  • Amiodarone Induced Thyrotoxicosis and Treatment Complications in a Man With Cyanotic Congenital Heart Disease: A Case Report
    Marvin Wei Jie Chua, Shao Feng Mok
    Frontiers in Cardiovascular Medicine.2020;[Epub]     CrossRef
  • Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves’ disease
    Patrícia Novais Rabelo, Paula Novais Rabelo, Allyne Fernanda de Paula, Samuel Amanso da Conceição, Daniela Pultrini Pereira de Oliveira Viggiano, Daniela Espíndola Antunes, Estela Muszkat Jatene, Sílvia Leda França Moura de Paula, Monike Lourenço Dias, Ma
    Revista da Associação Médica Brasileira.2019; 65(6): 755.     CrossRef
  • Notes on Trauma-Related Thyroid Storm in the Emergency Department
    Adam Morton
    The Journal of Emergency Medicine.2018; 54(2): e35.     CrossRef
  • Risk of embryopathies with use of antithyroidal medications
    Stine L. Andersen
    Current Opinion in Endocrinology, Diabetes & Obesity.2017; 24(5): 364.     CrossRef
  • Thiamazole

    Reactions Weekly.2017; 1644(1): 291.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism